Senmed, Inc. And Ethicon, Inc. v. Richard-Allan Medical Industries, Inc.

888 F.2d 815, 1989 WL 121293
CourtCourt of Appeals for the Federal Circuit
DecidedJanuary 4, 1990
Docket89-1091
StatusPublished
Cited by94 cases

This text of 888 F.2d 815 (Senmed, Inc. And Ethicon, Inc. v. Richard-Allan Medical Industries, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Senmed, Inc. And Ethicon, Inc. v. Richard-Allan Medical Industries, Inc., 888 F.2d 815, 1989 WL 121293 (Fed. Cir. 1990).

Opinions

MARKEY, Chief Judge.

Appeal from a judgment entered by the United States District Court for the Western District of Michigan, No. K 84-444, on a jury verdict that Richard-Allan Medical Industries, Inc. (Richard-Allan) failed to establish invalidity of U.S. Patent No. 4,109,844 (’844) and that Senmed, Inc. and Ethieon, Inc. (collectively Senmed) proved Richard-Allan’s willful infringement of that patent. We vacate in respect of validity and reverse in respect of infringement.

BACKGROUND

The claimed and accused devices are surgical staplers (skin staplers) that apply staples to close incisions or wounds. Unlike paper or stationery staplers, to which they are kin, skin staplers locate the staple-deforming anvil above the material to be stapled and deform the staple into a “box” shape rather than a tightly clenched configuration. Skin staples extend through the edges of skin tissue but remain open and able to flex when the tissue swells. To facilitate removal, the top of the staple is spaced slightly above the skin.

At trial, inventor Becht testified that, attributing unreliability of existing staplers to unnecessary complexity, he set forth to design a simpler device and focused on an area he considered the most complex, i.e., “the interface between where the staples are fed and where the staples were formed.”

Becht's effort led to the ’844 patent. Claim 1 reads:

A surgical stapling instrument for forming and implanting a staple in skin or fascia of a patient, said instrument comprising a handle portion incorporating a nose portion, said nose portion having an anvil plate at the bottom end thereof, said anvil plate terminating at its forward end in a coextensive anvil surface, said anvil plate being adapted-tee slidably mount a row of staples, means, to constantly urge and advance said row of staples along said anvil plate to place a forwardmost staple on said anvil surface, a staple driver mounted in said nose portion and shiftable vertically between a normal upper position closely adjacent said forwardmost staple on said anvil surface and a lower position wherein it forms and implants said forwardmost staple about said anvil surface, and Nmeawto shift said staple driver between SsalcFupper and lower position thereof.1

The Proceedings

On October 14, 1984, Senmed sued Richard-Allan, alleging, inter alia, infringement of the ’844 patent. Following an exhaustive six-week trial, the jury returned a verdict in the form of answers to questions on anticipation, obviousness, infringement, and willfulness:2

1. Do you unanimously find that the defendant Richard-Allan has proved by clear and convincing evidence that either of the asserted claims of the Becht 844 Patent is invalid because such claim was anticipated by a single prior art reference which disclosed each and every element of a claim arranged as in such claim?
[jury answer] Claim 1, no. Claim 2, no.
2. Do you unanimously find that the defendant Richard-Allan has proved by clear and convincing evidence that any of the asserted claims of the Becht 844 Patent is invalid because the differences between such claims and the pertinent prior art were such that the subject matter of [817]*817the claim as a whole would have been obvious to a person having ordinary skill in the pertinent art at the time of the invention?
[jury answer] Claim 1, no. Claim 2, no.
3. Do you unanimously find that the defendant Richard-Allan has infringed upon any of the asserted claims of the Becht 844 Patent?
[jury answer] Claim 1, yes. Claim 2, yes.
4. If you find the Becht 844 Patent infringed, do you unanimously find by clear and convincing evidence that Richard-Allan willfully infringed upon the Becht 844 Patent?
[jury answer] Yes.3

Richard-Allan moved for judgment NOV and for a new trial. Supplying a comprehensive opinion, the trial judge denied the motions and entered judgment in accord with the jury answers that constituted the verdict.

In his well written opinion, the trial judge discussed the evidence and Richard-Allan’s arguments in relation to literal infringement, infringement under the doctrine of equivalents, anticipation, obviousness, willful infringement, jury instructions, and an evidentiary ruling. The court noted that the credibility of Richard-Allan’s sole witness on anticipatory art could “reasonably be questioned.” Thrice noting that Richard-Allan “provided no testimony from an expert with ordinary skill in the art of skin stapling,” the court adopted inventor Becht’s claim-interpreting testimony in upholding jury answer 3 on infringement.

Richard-Allan here contends that certain of the jury's answers are unsupportable and that the trial judge therefore erred in refusing to enter judgment NOV. Admirably, it does not burden this court with challenges on the denial of its motion for a new trial, the correctness of any jury instruction, jury answer 1 (anticipation), or jury answer 4 (willfulness), but limits its appeal to jury answer 2 (obviousness) and jury answer 3 (infringement).

ISSUE

Whether the judgment entered on the jury verdict of infringement can be sustained in law.

OPINION

Introduction

To succeed here, Richard-Allan must show that the jury's finding of infringement is not supported by substantial evidence(or^hatit jvas made in relation to a claimjnterpretation that cannot ir£’law> be sustained. See ZMI Corp. v. Cardiac Resuscitator Corp., 844 F.2d 1576, 1581-82, 6 USPQ2d 1557, 1561-61 (Fed.Cir.1988). After careful review of the record, we are convinced that Richard-Allan satisfied the latter criterion. We must, therefore, reverse the judgment entered on the jury verdict of infringement.4

Richard-Allan says the “jury and the district court misconstrued the scope of claim 1" and that the claim, “properly construed,” cannot be read on its device. It argues that the claim limitation “means to constantly urge and advance said row of staples along said anvil plate to place a forwardmost staple on said anvil surface” cannot be read on its device because its advancing means places a forwardmost staple above its anvil. Stated differently, [818]*818Richard-Allan says “on” the anvil surface must be interpreted as meaning “in physical contact with” the anvil surface.5

There was, at the pretrial, trial, and post-trial stages, an intense focus on claim interpretation. That an appellant’s arguments had been ineptly pres.ente.d to a trial court does not in itself preclude a reversal by this court if the record unequivocally establishes that the appealed judgment resulted from clear and reversible legal error. We cannot and will not, as Richard-Allan would have us do, substitute our view of facts, or re-try the case, or ignore all the events that occurred before the appeal. Construction of claim scope (claim interpretation), however, is a question of law for decision by the trial judge on motion for JNOV and by this court on appeal. Johnston v. IVAC Corp., 885 F.2d 1574, 1579 (Fed.Cir.1989); Standard Oil Co. v. American Cyanamid Co.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Massachusetts Institute of Technology v. Micron Technology, Inc.
193 F. Supp. 3d 56 (D. Massachusetts, 2016)
Lamoureux v. AnazaoHealth Corp.
669 F. Supp. 2d 227 (D. Connecticut, 2009)
Eazypower Corp. v. Alden Corp.
509 F. Supp. 2d 737 (N.D. Illinois, 2007)
Phillips v. Awh Corporation
Federal Circuit, 2005
Astra Aktiebolag v. Andrx Pharmaceuticals, Inc.
222 F. Supp. 2d 423 (S.D. New York, 2002)
Ade Corp. v. KLA-Tencor Corp.
220 F. Supp. 2d 303 (D. Delaware, 2002)
Biagro Western Sales, Inc. v. Helena Chemical Co.
160 F. Supp. 2d 1112 (E.D. California, 2001)
John D. Watts v. Xl Systems, Inc.
232 F.3d 877 (Federal Circuit, 2000)
Angelo Mongiello's Children, LLC v. Pizza Hut, Inc.
70 F. Supp. 2d 196 (E.D. New York, 1999)
Wheeler v. Colgate-Palmolive Co.
42 F. Supp. 2d 516 (E.D. Pennsylvania, 1999)
Merck & Co., Inc. v. Mylan Pharmaceuticals, Inc.
19 F. Supp. 2d 334 (E.D. Pennsylvania, 1998)
Epic Metals Corp. v. Consolidated Systems, Inc.
19 F. Supp. 2d 1296 (M.D. Florida, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
888 F.2d 815, 1989 WL 121293, Counsel Stack Legal Research, https://law.counselstack.com/opinion/senmed-inc-and-ethicon-inc-v-richard-allan-medical-industries-inc-cafc-1990.